Mattias Ohlsson
Professor
Technical advances of the recombinant antibody microarray technology platform for clinical immunoproteomics
Författare
Summary, in English
In the quest for deciphering disease-associated biomarkers, high-performing tools for multiplexed protein expression profiling of crude clinical samples will be crucial. Affinity proteomics, mainly represented by antibody-based microarrays, have during recent years been established as a proteomic tool providing unique opportunities for parallelized protein expression profiling. But despite the progress, several main technical features and assay procedures remains to be (fully) resolved. Among these issues, the handling of protein microarray data, i.e. the biostatistics parts, is one of the key features to solve. In this study, we have therefore further optimized, validated, and standardized our in-house designed recombinant antibody microarray technology platform. To this end, we addressed the main remaining technical issues (e.g. antibody quality, array production, sample labelling, and selected assay conditions) and most importantly key biostatistics subjects (e.g. array data pre-processing and biomarker panel condensation). This represents one of the first antibody array studies in which these key biostatistics subjects have been studied in detail. Here, we thus present the next generation of the recombinant antibody microarray technology platform designed for clinical immunoproteomics.
Avdelning/ar
- Institutionen för immunteknologi
- Create Health
- Beräkningsbiologi och biologisk fysik - Har omorganiserats
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
Publiceringsår
2016-07-01
Språk
Engelska
Publikation/Tidskrift/Serie
PLoS ONE
Volym
11
Issue
7
Dokumenttyp
Artikel i tidskrift
Förlag
Public Library of Science (PLoS)
Ämne
- Medical Biotechnology
Status
Published
ISBN/ISSN/Övrigt
- ISSN: 1932-6203